Switch to:
Sanofi (NYSE:SNY)
Research and Development
$6,552 Mil (TTM As of Dec. 2014)

This is the expense the company spent on research and development. Sanofi's research and development for the three months ended in Dec. 2014 was $1,666 Mil. Its research and development for the trailing twelve months (TTM) ended in Dec. 2014 was $6,552 Mil.


Definition

This is the expense the company spent on research and development.

Sanofi Research & Development for the trailing twelve months (TTM) ended in Dec. 2014 was 1563.32453826 (Jun. 2013 ) + 1709.19067215 (Dec. 2013 ) + 1614.13043478 (Jun. 2014 ) + 1665.84463625 (Dec. 2014 ) = $6,552 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Related Terms

Gross Profit


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Sanofi Annual Data

Dec05Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13Dec14
Research & Development 4,7935,8526,6046,1826,6815,8216,3006,4376,5435,948

Sanofi Quarterly Data

Jun10Dec10Jun11Dec11Jun12Dec12Jun13Dec13Jun14Dec14
Research & Development 1,3201,4891,7251,6711,5501,7771,5631,7091,6141,666
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK